12 December 2018 0 3K Report

It is suggested that tumors frequently show oligoclonal origin, moreover, cell evolution produced more genetically related but different cell clones. Those about mentioned clones raised new challenge to the targeted therapy and genetic diagnosis. Currently the population based methods may address this issue partially. If any current technologies could ideally address poli/oligo-clonal, or sub-clones from the clonal evolution?

Similar questions and discussions